A highly soluble Sleeping Beauty transposase improves control of gene insertion-Reference-Cited by-同舟云学术

A highly soluble Sleeping Beauty transposase improves control of gene insertion

Published:2019-11-04 Issue:12 Volume:37 Page:1502-1512
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Querques Irma^ORCID,Mades Andreas,Zuliani Cecilia^ORCID,Miskey Csaba^ORCID,Alb Miriam^ORCID,Grueso Esther,Machwirth Markus,Rausch Tobias^ORCID,Einsele Hermann,Ivics Zoltán^ORCID,Hudecek Michael^ORCID,Barabas Orsolya^ORCID

Funder

European Molecular Biology Laboratory

EMBL International PhD Programme

Paul Ehrlich Institute

Hessisches Ministerium für Wissenschaft und Kunst

Deutsche Krebshilfe

Bayerische Akademie der Wissenschaften

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/s41587-019-0291-z.pdf

Reference75 articles.

1. Turtle, C. J. et al. Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib. J. Clin. Oncol. 35, 3010–3020 (2017).

2. Klebanoff, C. A., Rosenberg, S. A. & Restifo, N. P. Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat. Med. 22, 26–36 (2016).

3. Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439–448 (2018).

4. Lamers, C. H. et al. Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells. Blood 117, 72–82 (2011).

5. Bushman, F. et al. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3, 848–858 (2005).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system;PLOS ONE;2024-08-27

2. Chimäre Antigenrezeptor-T-Zellen – Die Evolution zellulärer Immuntherapie von malignen zu nicht-malignen Erkrankungen;Aktuelle Rheumatologie;2024-08

3. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods;Life Sciences;2024-07

4. Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors;Molecular Therapy;2024-07

5. Augmenting the landscape of chimeric antigen receptor T-cell therapy;Expert Review of Anticancer Therapy;2024-06-26